Compare Stocks: CODX, GUTS, ESLA, and BKHA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BKHA Black Hawk Acquisition	$5.40 +25.9%	$10.97	$3.70 ▼ $23.00	$17.82M	0.02	47,134 shs	193,382 shs
CODX Co-Diagnostics	$0.55 -4.3%	$1.06	$0.53 ▼ $46.50	$3.98M	2.9	396,661 shs	283,278 shs
ESLA Estrella Immunopharma	$0.99 +35.5%	$0.57	$0.24 ▼ $3.15	$31.61M	0.93	5.24 million shs	3.66 million shs
GUTS Fractyl Health	$1.08 -4.4%	$6.19	$1.06 ▼ $29.34	$14.98M	2.42	1.07 million shs	432,819 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BKHA Black Hawk Acquisition	+25.87%	-10.15%	-55.39%	-54.89%	-52.00%
CODX Co-Diagnostics	-4.30%	-16.59%	-50.41%	-74.02%	-94.30%
ESLA Estrella Immunopharma	+35.53%	+129.07%	+108.69%	+26.28%	-57.73%
GUTS Fractyl Health	-4.42%	-30.32%	-81.47%	-88.36%	-93.18%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BKHA Black Hawk Acquisition	$5.40 +25.9%	$10.97	$3.70 ▼ $23.00	$17.82M	0.02	47,134 shs	193,382 shs
CODX Co-Diagnostics	$0.55 -4.3%	$1.06	$0.53 ▼ $46.50	$3.98M	2.9	396,661 shs	283,278 shs
ESLA Estrella Immunopharma	$0.99 +35.5%	$0.57	$0.24 ▼ $3.15	$31.61M	0.93	5.24 million shs	3.66 million shs
GUTS Fractyl Health	$1.08 -4.4%	$6.19	$1.06 ▼ $29.34	$14.98M	2.42	1.07 million shs	432,819 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BKHA Black Hawk Acquisition	+25.87%	-10.15%	-55.39%	-54.89%	-52.00%
CODX Co-Diagnostics	-4.30%	-16.59%	-50.41%	-74.02%	-94.30%
ESLA Estrella Immunopharma	+35.53%	+129.07%	+108.69%	+26.28%	-57.73%
GUTS Fractyl Health	-4.42%	-30.32%	-81.47%	-88.36%	-93.18%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BKHA Black Hawk Acquisition	1.00	Sell	N/A	N/A
CODX Co-Diagnostics	2.50	Moderate Buy	$67.50	12,273.97% Upside
ESLA Estrella Immunopharma	2.00	Hold	$8.00	712.18% Upside
GUTS Fractyl Health	2.40	Hold	$50.25	4,552.78% Upside

Current Analyst Ratings Breakdown

Latest CODX, GUTS, ESLA, and BKHA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/19/2026	GUTS Fractyl Health	Craig Hallum Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$5.00
10/19/2026	GUTS Fractyl Health	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Equal Weight	$4.00
10/15/2026	BKHA Black Hawk Acquisition	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
10/13/2026	ESLA Estrella Immunopharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/24/2026	ESLA Estrella Immunopharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/8/2026	CODX Co-Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/8/2026	ESLA Estrella Immunopharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/3/2026	GUTS Fractyl Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/25/2026	ESLA Estrella Immunopharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	GUTS Fractyl Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/18/2026	CODX Co-Diagnostics	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy

(Data available from 10/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	$620K	6.14	N/A	N/A	$9.14 per share	0.06
ESLA Estrella Immunopharma	N/A	N/A	N/A	N/A	($0.27) per share	N/A
GUTS Fractyl Health	$90K	159.12	N/A	N/A	$0.83 per share	1.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	-$46.90M	-$10.32	N/A	N/A	N/A	-6,531.77%	-210.99%	-174.97%	11/5/2026 (Estimated)
ESLA Estrella Immunopharma	-$13.06M	-$0.24	N/A	N/A	N/A	N/A	N/A	-328.72%	12/2/2026 (Estimated)
GUTS Fractyl Health	-$140.95M	-$10.56	N/A	N/A	N/A	N/A	-1,362.10%	-84.89%	11/11/2026 (Estimated)

Latest CODX, GUTS, ESLA, and BKHA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/16/2026	Q3 2026	CODX Co-Diagnostics	-$1.25	N/A	N/A	N/A	$0.17 million	N/A
11/11/2026	Q3 2026	GUTS Fractyl Health	-$1.5680	N/A	N/A	N/A	N/A	N/A
10/6/2026	Q3 2026	BKHA Black Hawk Acquisition	N/A	$0.26	N/A	$0.26	N/A	N/A
8/13/2026	Q2 2026	CODX Co-Diagnostics	-$3.00	-$1.46	+$1.54	-$1.46	$0.13 million	$0.17 million
8/13/2026	Q2 2026	ESLA Estrella Immunopharma	-$0.09	-$0.05	+$0.04	-$0.05	N/A	N/A
8/10/2026	Q2 2026	GUTS Fractyl Health	-$1.62	-$1.44	+$0.18	-$0.16	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	N/A	N/A	N/A	N/A
ESLA Estrella Immunopharma	N/A	N/A	N/A	N/A	N/A
GUTS Fractyl Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BKHA Black Hawk Acquisition	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	1.81	1.52
ESLA Estrella Immunopharma	N/A	0.20	0.20
GUTS Fractyl Health	1.41	3.15	3.15

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BKHA Black Hawk Acquisition	N/A
CODX Co-Diagnostics	14.99%
ESLA Estrella Immunopharma	0.35%
GUTS Fractyl Health	N/A

Insider Ownership

Company	Insider Ownership
BKHA Black Hawk Acquisition	N/A
CODX Co-Diagnostics	2.30%
ESLA Estrella Immunopharma	5.80%
GUTS Fractyl Health	8.36%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BKHA Black Hawk Acquisition	2	4.15 million	N/A	N/A
CODX Co-Diagnostics	115	6.98 million	6.82 million	No Data
ESLA Estrella Immunopharma	N/A	43.50 million	40.98 million	Not Optionable
GUTS Fractyl Health	73	13.26 million	12.15 million	N/A

CODX, GUTS, ESLA, and BKHA Headlines

Recent News About These Companies

H.C. Wainwright Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)

October 23 at 5:59 PM | theglobeandmail.com $https://www.theglobeandmail.com/investing/markets/stocks/GUTS/pressreleases/8371062/hc-wainwright-keeps-their-buy-rating-on-fractyl-health-inc-guts/$

Fractyl Health consensus price target increased by 917.27% to $46.07

October 23 at 7:56 AM | msn.com $https://www.msn.com/en-us/health/general/fractyl-health-consensus-price-target-increased-by-917-27-to-46-07/ar-AA2fUmdp$

Fractyl Health Announces 45% Staff Reduction, President Caplan Retires Amid Strategic Shift

October 22 at 4:55 PM | kalkinemedia.comK

Fractyl Health, Inc. Announces Executive Changes

October 22 at 11:54 AM | marketscreener.comM

Fractyl Health (GUTS) Stock Sees Fair Value Cut After Mixed Revita Analyst Reactions

October 22 at 11:54 AM | finance.yahoo.com $https://finance.yahoo.com/markets/stocks/articles/fractyl-health-guts-stock-sees-131123108.html$

Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

October 22 at 7:00 AM | globenewswire.com $https://www.globenewswire.com/news-release/2026/10/22/3386191/0/en/fractyl-health-sharpens-focus-on-revita-following-positive-pivotal-results-advancing-toward-planned-fda-de-novo-submission-in-post-glp-1-weight-maintenance.html$

Morgan Stanley Has Lowered Expectations for Fractyl Health (NASDAQ:GUTS) Stock Price

October 21 at 1:48 AM | americanbankingnews.com

Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers – GUTS

October 20, 2026 | globenewswire.com $https://www.globenewswire.com/news-release/2026/10/20/3384847/1087/en/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-fractyl-health-inc-and-certain-officers-guts.html$

GUTS CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Fractyl (NASDAQ: GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

October 20, 2026 | businesswire.com $https://www.businesswire.com/news/home/20261020695255/en/guts-class-action-deadline-tonight-faruqi-faruqi-llp-reminds-fractyl-nasdaq-guts-investors-of-securities-class-action-lawsuit-deadline-on-october-20-2026/$

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Fractyl Health, Inc. to Contact Law Firm

October 19, 2026 | prnewswire.com $https://www.prnewswire.com/news-releases/investor-action-notice-moore-law-pllc-encourages-investors-in-fractyl-health-inc-to-contact-law-firm-302913147.html$

GUTS DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Fractyl (GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

October 19, 2026 | newsfilecorp.comN

Deadline Alert: Fractyl Health, Inc. Investors Have Until October 20, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds

October 19, 2026 | globenewswire.com $https://www.globenewswire.com/news-release/2026/10/19/3383904/34548/en/deadline-alert-fractyl-health-inc-investors-have-until-october-20-2026-to-seek-lead-plaintiff-role-in-securities-fraud-class-action-glancy-prongay-wolke-rotter-llp-reminds.html$

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

October 19, 2026 | globenewswire.com $https://www.globenewswire.com/news-release/2026/10/19/3383711/9788/en/bronstein-gewirtz-grossman-llc-urges-fractyl-health-inc-investors-to-act-class-action-filed-alleging-investor-harm.html$

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS

October 19, 2026 | globenewswire.com $https://www.globenewswire.com/news-release/2026/10/19/3383585/3080/en/levi-korsinsky-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-20-2026-in-fractyl-health-inc-lawsuit-guts.html$

Fractyl Health’s Revita Hits Key Weight-Maintenance Goal in REMAIN-1 Study

October 19, 2026 | americanbankingnews.com

Comparing Fractyl Health (NASDAQ:GUTS) and Zealand Pharma A/S (OTCMKTS:ZLDPF)

October 18, 2026 | americanbankingnews.com

GUTS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Fractyl (GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

October 17, 2026 | newsfilecorp.comN

Fractyl Health, Inc. (GUTS) Discusses Positive Top Line 6-Month Results From REMAIN-1 Study of Revita in Post GLP-1 Weight Maintenance Transcript

October 16, 2026 | seekingalpha.com $https://seekingalpha.com/article/4954836-fractyl-health-inc-guts-discusses-positive-top-line-6-month-results-from-remainminus-1-study$

Fractyl Health Stock Plunges 48% Despite Positive Revita Weight-Maintenance Trial Results

October 16, 2026 | rttnews.com $https://www.rttnews.com/3699844/fractyl-health-stock-plunges-48-despite-positive-revita-weight-maintenance-trial-results.aspx$

Fractyl announces pivotal data for post-GLP-1 weight loss maintenance

October 16, 2026 | thepharmaletter.comT

Fractyl Health, Inc. (NASDAQ:GUTS) Stock Now Rated "Hold" by Sell-Side Brokerages

October 13, 2026 | marketbeat.com $https://www.marketbeat.com/instant-alerts/consensus-fractyl-health-inc-nasdaq-guts-stock-now-rated-hold-by-sell-side-brokerages-2026-10-13/$

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CODX, GUTS, ESLA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

$5.40 +1.11 (+25.87%)

Closing price 10/23/2026 03:56 PM Eastern

Extended Trading

$5.32 -0.08 (-1.41%)

As of 10/23/2026 07:59 PM Eastern

Black Hawk Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in Danville, California.

Co-Diagnostics NASDAQ:CODX

$0.55 -0.02 (-4.30%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$0.55 +0.00 (+0.27%)

As of 10/23/2026 07:13 PM Eastern

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Estrella Immunopharma NASDAQ:ESLA

$0.98 +0.26 (+35.53%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$0.97 -0.02 (-1.52%)

As of 10/23/2026 07:59 PM Eastern

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Fractyl Health NASDAQ:GUTS

$1.08 -0.05 (-4.42%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$1.07 -0.01 (-0.93%)

As of 10/23/2026 07:59 PM Eastern

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CODX, GUTS, ESLA, and BKHA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CODX, GUTS, ESLA, and BKHA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CODX, GUTS, ESLA, and BKHA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CODX, GUTS, ESLA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

Co-Diagnostics NASDAQ:CODX

Estrella Immunopharma NASDAQ:ESLA

Fractyl Health NASDAQ:GUTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CODX, GUTS, ESLA, and BKHA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CODX, GUTS, ESLA, and BKHA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CODX, GUTS, ESLA, and BKHA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CODX, GUTS, ESLA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

Co-Diagnostics NASDAQ:CODX

Estrella Immunopharma NASDAQ:ESLA

Fractyl Health NASDAQ:GUTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools